Πρέπει η κυβέρνηση να ρυθμίζει τις τιμές των σωτήριων για τη ζωή φαρμάκων;
Ναι, και η κυβέρνηση πρέπει να ρυθμίζει τις τιμές όλων των συνταγογραφούμενων φαρμάκων
We have to find a healthy balance between grotesque oversight that hinders our research and development and cripples incentive, and Corporate greed that hurts its customers/patients to the degree of not only attacking the current healthcare system but hurts the outlook of their own product. Collateral damage must be acknowledged and addressed by both sides of the docket. Punitive measures have always stalled progress while incentives have at least proven a percentage of success for all. We should chase for a more perfect incentive system as if it were written in the preamble itself!
Γίνετε ο πρώτος που θα απαντήσετε σε αυτήν τη Διαφωνία .